MONTREAL–(BUSINESS WIRE)–Emovi, Inc., a leading developer and manufacturer of medical devices for orthopedics, today announced a clinical collaboration with the U.S. military in partnership with the Geneva Foundation and a support grant from the Ministry of Economy and Innovation of Quebec. With the installation of three KneeKG systems, the project will demonstrate the functionality and performance of Emovi’s AI platform combined with its KneeKG technology to the military health system.
“Knee pain affects one in five people and includes sports injuries and structural diseases such as osteoarthritis of the knee (‘OA’), which is one of the leading causes of disability in the United States, costing billions of dollars each year in lost work hours, treatments and doctor visits, and leaves people sidelined from day-to-day activities,” said Michelle Laflamme, President and CEO of Emovi. heavy loads, such as body armor, heavy boots, backpacks and weapons, this problem is reflected and even amplified in the military, affecting both active soldiers and veterans. Treating knee problems in the military is no different from the challenge faced by clinicians. , but more complex due to the many stresses exerted on the knees of the military. There just aren’t many treatment options for knee pain outside of pain management and, possibly, surgery.
Laflamme continued, “Our partnership with the Geneva Foundation is extremely valuable, and the grant from the Quebec Ministry of Economy and Innovation allows us to bring our solutions to military clinics. Specifically for military veterans who have served in multiple ways, often putting their lives on the line for their county. Veterans are used to an active lifestyle, and knee damage can make mobility a problem. This project gives active duty military members access to new AI-based technology to help them return to an active lifestyle.”
“For years I have served in the military in various clinical assignments and I am acutely aware of the challenges our military men and women face in training and combat,” said Don Goss, PhD. , retired U.S. Army colonel and associate professor at High Point. University. “Running, jumping, climbing, and other training activities required of soldiers put significant pressure on the knee joints. KneeKG and Emovi’s artificial intelligence platform will be a tool providing unprecedented data on knee kinematics, identifying misalignments. I am very excited to see how dynamic information can help clinicians determine the best course of action for rehabilitation and effective care.”
The KneeKG system provides a dynamic knee examination that helps diagnose the causes of knee pain and symptoms. This procedure is known as a kinesiography examination of the knee. The examination complements imaging such as X-rays and MRIs that historically provide static information about bones and soft tissues; however, KneeKG technology successfully identifies and analyzes different biomechanical markers, generating an accurate profile and functional score of the knee. The results, combined with the Emovi AI platform, produce a care algorithm that includes a targeted program to support the return of strength, function and, most importantly, the dynamic alignment of the patient’s knee. From a surgical perspective, the results include objective and reproducible data defining dynamic knee flexion contracture, tibial rotation and varus thrust of the loaded and articulated knee for surgical planning and robotic/navigated surgery. Additionally, it is used to understand and treat residual pain and post-operative functional impairments.
“The mission of the Geneva Foundation is to advance military medicine through innovative scientific research, exceptional program management, and dedication to American service members and veterans, their families, and the global community,” said Elise Huszar, CEO of Geneva. “The knowledge gained from this project addresses treatment options for a better pain-free quality of life for our service members.”
“Research and innovation have become essential for Quebec companies that want to shine on the international scene. Emovi is a good example. By combining artificial intelligence with its KneeKG technology, it managed to sign an important collaboration contract with the American army. We must continue to support the innovation of Quebec businesses to conquer new markets, reduce health costs and generate economic spinoffs here in Quebec,” said the Minister of Economy and Innovation and Minister responsible for Development. regional economist, Pierre Fitzgibbon.
Investissement Québec International’s export development team, in partnership with the Québec delegation based in Boston, supported Emovi in its market development and growth activities in the United States. “The announcement of this collaboration between Emovi and the U.S. military confirms the crucial role played by Investissement Québec International, together with Québec offices abroad, to support our companies in their growth projects outside Québec,” said declared Hubert Bolduc, President of Investissement Québec International. “Our experts based in Quebec and the United States have been supporting Emovi in its expansion activities for many years, and we will remain by their side to promote their expertise on the international scene.”
The project will run for twenty-four months, and the clinical data collected throughout the project will be used to support effective return to work activities for all knee conditions and only use the data in a triage setting to determine if an intervention Surgical or not a surgical approach is necessary to treat and correct knee conditions. The data will also support personalized prevention strategies and programs and develop evidence-based approaches for future clinical practice guidelines for active military and veterans.
The project will be carried out in the following three clinics:
Womack Army Medical Center 2817 Reilly Road, Fort Bragg, NC 28310
Human Biomechanics and Physiology Laboratory Clinic, One University Parkway, High Point University 27268
Pro Bono Clinic, One University Parkway, High Point University 27268
About Emovi Inc.
Emovi’s AI technologies and solutions address clinical challenges that exist across the continuum of care for patients with knee pain and pathologies. These challenges include patient engagement, preoperative planning, digital and robotic surgery, postoperative assessment, and outcome measurement. Our mission is to transform the musculoskeletal healthcare landscape to facilitate efficient and effective medical care pathways that support active and healthy lifestyles for all patient populations. In partnership with the Quebec university research community, including the CRCHUM, the École de technologie supérieure (ETS) and TÉLUQ, Emovi has completed the development of the KneeKGMT, an FDA 510K cleared medical device, licensed by Health Canada and CE marked, suitable for assessing 3D knee motion in patients with impaired movement functions due to an orthopedic cause. The technique is described as a kinesiography examination of the knee. www.emovi.ca
About the Geneva Foundation
The Geneva Foundation is a 501(c)3 nonprofit organization that advances military medicine through innovative scientific research, exceptional program management, and dedication to U.S. service members and veterans, their families, and the global community. . Geneva is proud to have over 25 years of experience providing full-spectrum scientific, technical and program management expertise in the areas of federal grants, federal contracts, industry-sponsored clinical trials and educational services. http://www.genevaUSA.org